Tulane University Hospital and Clinics
New Orleans, Louisiana, 70112, United States
NCT Number: NCT01539135
Surgical patients have an endotracheal tube inserted into their windpipe to help them breathe while under general anesthesia. These tubes have a "cuff" on the outside that is inflated in the trachea to help prevent fluids from leaking into the lungs. These cuffs come in different shapes and sizes. The TaperGuard endotracheal tube has a taper-shaped cuff that has been shown in animals to decrease the leakage of fluid past the cuff better than a traditional tube that has a barrel-shaped cuff. This study is designed to examine whether the use of the TaperGuard tube during surgery on humans decreases the amount of leakage past the cuff to a greater degree than the traditional barrel-shaped cuff. In addition, the study will investigate whether the use of the TaperGuard tube is associated with a decrease in respiratory complications often seen following surgery which may be related to fluid leaking past the cuff and into the lungs. It is thought that the use of the TaperGuard endotracheal tube will result in a decrease in fluid leakage past the cuff and that it will be associated with a decrease in respiratory complications during the 30 days after surgery.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
New Orleans, Louisiana, 70112, United States
This study is designed to yield data on the intraoperative use of TaperGuard™endotracheal tubes and its potential influence on postoperative pulmonary complications and outcomes. The TaperGuard Basic tube has a taper-shaped cuff and has been shown, via bench and animal testing, to decrease microaspiration, which has been associated with respiratory difficulties. The intraoperative use of this tube (i.e. during short term intubation), and its impact on postoperative complications and outcomes has not been investigated. This study will determine whether the intraoperative use of the TaperGuard tube results in a decrease in microaspiration compared to the Hi-Lo endotracheal tube having a barrel-shaped cuff. Moreover, the relationship between a decrease in microaspiration and subsequent decrease in postoperative respiratory complications will be explored.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
20 cc methylene blue instilled above the cuff once after intubation for the duration of the surgical procedure
Other names: Methylene Blue Dye
Time frame: Duration of surgical procedure - from 2 to 12 hours
Blue dye will be instilled above the endotracheal tube cuff immediately after intubation where it will remain for the duration of the surgery. The presence of dye leakage past the endotracheal tube cuff will be determined via analysis of bronchoscopic images taken at the end of the surgical procedure when surgical closure has begun.
Time frame: Time from discharge from PACU to discharge from hospital up to 72 hours
Time of readiness for discharge from PACU, defined as when an Aldrete score of greater than or equal to 8 is given, to the time at which discharge (from the hospital) orders are written. The inpatient period may extend up to 72 hours.
Time frame: Up to 30 days after surgery
Diagnosis of postoperative pneumonia during the 30 day follow up period after surgery
Time frame: Time from discharge from PACU to discharge from hospital up to 72 hours
Incidence of unscheduled Intensive Care Unit admission after surgery and length of ICU stay if applicable.
Medtronic - MITG
Industry
The Influence of Endotracheal Tube Cuff Design on Intraoperative Microaspiration and Postoperative Respiratory Complications
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06039852
Pathologic Processes, Pathological Conditions, Signs and Symptoms
Brighton, East Sussex, United Kingdom
View Trial DetailsNCT02935946
Deglutition Disorders, Digestive System Diseases
Mineola, New York, United States
View Trial DetailsNCT02661256
Deglutition Disorders, Digestive System Diseases
View Trial DetailsNCT01980108
Pathologic Processes, Pathological Conditions, Signs and Symptoms
Toronto, Ontario, Canada
View Trial Details